arrow
N

Naruto Taira

Department of Breast and Thyroid Surgery
H指数:28
被引数:2,402

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Effects of exercise and educational programs on long-term quality of life, anxiety, and depression in breast cancer survivors: an exploratory secondary analysis of the Setouchi breast project-10 randomized controlled trial

运动和教育项目对乳腺癌幸存者长期生活质量、焦虑和抑郁的影响:Setouchi乳腺癌项目-10随机对照试验的探索性二次分析

2026-10-030
PRE
Real-world data for a CDK4/6 inhibitor, palbociclib, as 1st- or 2nd-line therapy in HR+/HER2− metastatic breast cancer: a multicenter prospective cohort study

帕博西利(palbociclib)作为HR+/HER2−转移性乳腺癌的一线或二线治疗的真实世界数据:一项多中心前瞻性队列研究

2026-05-290
OAAI
Health-related quality of life with pertuzumab retreatment: Secondary analysis of the PRECIOUS trial

接受帕妥珠单抗再治疗患者的生活质量:PRECIOUS试验的二次分析

Breast
IF7.9
2026-05-230
OAAI
Electronic patient-reported outcome monitoring system for sarcoma patients undergoing drug treatment: a development and feasibility study

肉瘤药物治疗的电子患者报告结局监测系统:一项开发与可行性研究

2026-05-190
OA
Quality-of-life outcomes with pimitespib in patients with advanced gastrointestinal stromal tumor: results from the randomized, double-blind, placebo-controlled, phase III, CHAPTER-GIST-301 study

接受pimitespib治疗晚期胃肠道间质瘤患者的生命质量结局:来自随机、双盲、安慰剂对照的III期CHAPTER-GIST-301研究的成果

2026-03-040
OAAI
HER2DX in older patients with HER2-positive early breast cancer: extended follow-up from the RESPECT trial of trastuzumab ± chemotherapy

HER2DX在HER2阳性早期乳腺癌老年患者中的应用:来自RESPECT试验中曲妥珠单抗±化疗的扩展随访研究

2025-11-040
OAAI
Annual report of National Clinical Database-Breast Cancer Registry in 2021: characteristics categorized by body mass index and menopause status

2021年国家临床数据库—乳腺癌登记系统年度报告:按体重指数和绝经状态分类的特征

2025-04-210
OA
Validation of the Symptom Illustration Scale within an electronic Patient-Reported Outcomes Monitoring environment for metastatic breast cancer patients undergoing chemotherapy

在接受化疗的转移性乳腺癌患者的电子患者报告结果监测环境中验证症状插图量表

2025-04-010
PRE
Breast cancer statistics for Japan in 2022: annual report of the national clinical database-breast cancer registry-clinical implications including chemosensitivity of breast cancer with low estrogen receptor expression
2025-02-060
OAAI
Real-world incidence of and risk factors for abemaciclib-induced interstitial lung disease in Japan: a nested case-control study of abemaciclib-induced interstitial lung disease (NOSIDE)
2024-11-180
PRE
Eribulin versus S-1 as fi rst or second-line chemotherapy to assess health-related quality of life and overall survival in HER2-negative metastatic breast cancer (RESQ study): a noninferiority, randomised, controlled, open-label, phase 3 trial
2024-08-010
OAAI
The effect of exercise and educational programs for breast cancer patients on the development of breast cancer-related lymphoedema: secondary endpoint from a randomized controlled trial in the Setouchi Breast Project-10
2024-07-091
PRE
Baseline gut microbiota as a predictive marker for the efficacy of neoadjuvant chemotherapy in patients with early breast cancer: a multicenter prospective cohort study in the Setouchi Breast Project-14
2024-06-181
PRE
The Japanese Breast Cancer Society Clinical Practice Guidelines for Breast Cancer, 2022 Edition: changes from the 2018 edition and general statements on breast cancer treatment (vol 31, pg 340, 2024)
2024-05-121
OAAI